amgen glp-1 A GIPR antagonist conjugated to analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Amgen playing in the GLP-1

Nutrition plays a crucial role when taking GLP-1 medication for weight loss, which has transformed medical approaches to managing obesity.

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field

Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

Attorney and consumer safety advocate Whitney Ray Di Bona takes an inside look at how GLP-1 drugs like Ozempic are marketed online.

Thinking about a GLP-1 medication